{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:50Z","timestamp":1781650790709,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["L254026"],"award-info":[{"award-number":["L254026"]}]},{"name":"National Key Research and Development Program of China","award":["2016YFC1300104"],"award-info":[{"award-number":["2016YFC1300104"]}]},{"name":"National Health Commission Foundation","award":["WKZX2022JG0151"],"award-info":[{"award-number":["WKZX2022JG0151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02929-y","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:55:58Z","timestamp":1777082158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) concentration, kringle IV-2 repeat copy number, and myocardial infarction risk in Chinese populations: insights from the INTERHEART China study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinsong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"10226","key":"2929_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London England). 2020;395(10226):795\u2013808.","journal-title":"Lancet (London England)"},{"issue":"22","key":"2929_CR2","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1136\/hrt.2008.155796","volume":"95","author":"KK Teo","year":"2009","unstructured":"Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, et al. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart. 2009;95(22):1857\u201364.","journal-title":"Heart"},{"issue":"9","key":"2929_CR3","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/hrt.2007.132423","volume":"94","author":"X-H Zhang","year":"2008","unstructured":"Zhang X-H, Lu ZL, Liu L. Coronary heart disease in China. Heart. 2008;94(9):1126\u201331.","journal-title":"Heart"},{"issue":"9438","key":"2929_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London England). 2004;364(9438):937\u201352.","journal-title":"Lancet (London England)"},{"issue":"1","key":"2929_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","volume":"273","author":"F Kronenberg","year":"2013","unstructured":"Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2013;273(1):6\u201330.","journal-title":"J Intern Med"},{"issue":"26","key":"2929_CR6","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518\u201328.","journal-title":"N Engl J Med"},{"key":"2929_CR7","doi-asserted-by":"crossref","unstructured":"Berglund L, Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(12):2219\u201326.","DOI":"10.1161\/01.ATV.0000144010.55563.63"},{"issue":"12","key":"2929_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","volume":"139","author":"G Par\u00e9","year":"2019","unstructured":"Par\u00e9 G, \u00c7aku A, McQueen M, Anand SS, Enas E, Clarke R, et al. Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups. Circulation. 2019;139(12):1472\u201382.","journal-title":"Circulation"},{"issue":"11","key":"2929_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1373\/clinchem.2003.023689","volume":"49","author":"SM Marcovina","year":"2003","unstructured":"Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem. 2003;49(11):1785\u201396.","journal-title":"Clin Chem"},{"issue":"4","key":"2929_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1194\/jlr.D800050-JLR200","volume":"50","author":"MB Lanktree","year":"2009","unstructured":"Lanktree MB, Rajakumar C, Brunt JH, Koschinsky ML, Connelly PW, Hegele RA. Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR. J Lipid Res. 2009;50(4):768\u201372.","journal-title":"J Lipid Res"},{"issue":"9497","key":"2929_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","volume":"366","author":"S Yusuf","year":"2005","unstructured":"Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (London England). 2005;366(9497):1640\u20139.","journal-title":"Lancet (London England)"},{"issue":"9438","key":"2929_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","volume":"364","author":"A Rosengren","year":"2004","unstructured":"Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet (London England). 2004;364(9438):953\u201362.","journal-title":"Lancet (London England)"},{"issue":"8","key":"2929_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1194\/jlr.R067314","volume":"57","author":"K Schmidt","year":"2016","unstructured":"Schmidt K, Noureen A, Kronenberg F, Utermann G. Structure, function, and genetics of lipoprotein (a). J Lipid Res. 2016;57(8):1339\u201359.","journal-title":"J Lipid Res"},{"issue":"22","key":"2929_CR14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301(22):2331\u20139.","journal-title":"JAMA"},{"issue":"1","key":"2929_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","volume":"67","author":"PR Kamstrup","year":"2021","unstructured":"Kamstrup PR. Lipoprotein(a) and Cardiovascular Disease. Clin Chem. 2021;67(1):154\u201366.","journal-title":"Clin Chem"},{"issue":"3","key":"2929_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joim.12187","volume":"276","author":"JC Hopewell","year":"2014","unstructured":"Hopewell JC, Seedorf U, Farrall M, Parish S, Kyriakou T, Goel A, et al. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease. J Intern Med. 2014;276(3):260\u20138.","journal-title":"J Intern Med"},{"issue":"8","key":"2929_CR17","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1074\/jbc.272.8.5048","volume":"272","author":"AL White","year":"1997","unstructured":"White AL, Guerra B, Lanford RE. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J Biol Chem. 1997;272(8):5048\u201355.","journal-title":"J Biol Chem"},{"issue":"2","key":"2929_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0022-2275(20)33376-9","volume":"40","author":"E Angl\u00e9s-Cano","year":"1999","unstructured":"Angl\u00e9s-Cano E, Loyau S, Cardoso-Salda\u00f1a G, Couderc R, Gillery P. A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping. J Lipid Res. 1999;40(2):354\u20139.","journal-title":"J Lipid Res"},{"issue":"12","key":"2929_CR19","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1111\/j.1538-7836.2008.03183.x","volume":"6","author":"NT Feric","year":"2008","unstructured":"Feric NT, Boffa MB, Johnston SM, Koschinsky ML. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation. J Thromb haemostasis: JTH. 2008;6(12):2113\u201320.","journal-title":"J Thromb haemostasis: JTH"},{"issue":"5","key":"2929_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrg.2017.115","volume":"19","author":"AJ Hannan","year":"2018","unstructured":"Hannan AJ. Tandem repeats mediating genetic plasticity in health and disease. Nat Rev Genet. 2018;19(5):286\u201398.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2929_CR21","first-page":"69","volume":"73","author":"M Zhao","year":"2021","unstructured":"Zhao M, Liu B-Y, Qin S-C. [Oxidized phospholipids and atherosclerosis]. Sheng Li Xue Bao. 2021;73(1):69\u201381.","journal-title":"Sheng Li Xue Bao"},{"issue":"15","key":"2929_CR22","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jacc.2010.10.052","volume":"57","author":"E Merki","year":"2011","unstructured":"Merki E, Graham M, Taleb A, Leibundgut G, Yang X, Miller ER, et al. Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice. J Am Coll Cardiol. 2011;57(15):1611\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2929_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/biof.1890","volume":"48","author":"D Pantazi","year":"2022","unstructured":"Pantazi D, Tellis C, Tselepis AD. Oxidized phospholipids and lipoprotein-associated phospholipase A2 (Lp-PLA2) in atherosclerotic cardiovascular disease: An update. Biofactors. 2022;48(6):1257\u201370.","journal-title":"Biofactors"},{"issue":"2","key":"2929_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.ejhg.5200290","volume":"7","author":"M Scholz","year":"1999","unstructured":"Scholz M, Kraft HG, Lingenhel A, Delport R, Vorster EH, Bickeb\u00f6ller H, et al. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum genetics: EJHG. 1999;7(2):169\u201378.","journal-title":"Eur J Hum genetics: EJHG"},{"issue":"6","key":"2929_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.124.069210","volume":"151","author":"A Greco","year":"2025","unstructured":"Greco A, Finocchiaro S, Spagnolo M, Faro DC, Mauro MS, Raffo C, et al. Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects. Circulation. 2025;151(6):400\u201315.","journal-title":"Circulation"},{"issue":"1","key":"2929_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"key":"2929_CR27","doi-asserted-by":"crossref","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, thrombosis, and vascular biology. 2022;42(1):e48\u201360.","DOI":"10.1161\/ATV.0000000000000147"},{"issue":"18","key":"2929_CR28","doi-asserted-by":"publisher","first-page":"e031255","DOI":"10.1161\/JAHA.123.031255","volume":"12","author":"HS Bhatia","year":"2023","unstructured":"Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. J Am Heart Association. 2023;12(18):e031255.","journal-title":"J Am Heart Association"},{"issue":"9","key":"2929_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11883-024-01225-3","volume":"26","author":"G Bosco","year":"2024","unstructured":"Bosco G, Mszar R, Piro S, Sabouret P, Gallo A. Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia. Curr Atheroscler Rep. 2024;26(9):537\u201348.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"2929_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4093\/dmj.2024.0537","volume":"49","author":"M Yang","year":"2025","unstructured":"Yang M, Wei Y, Liu J, Wang Y, Wang G. Contributions of Hepatic Insulin Resistance and Islet \u03b2-Cell Dysfunction to the Blood Glucose Spectrum in Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes metabolism J. 2025;49(4):883\u201392.","journal-title":"Diabetes metabolism J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02929-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:42:11Z","timestamp":1781649731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02929-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2929"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02929-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committees of all participating centers (Approval No.: EC-2004-CHN-001), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Obtained according to Ethic Committee\u2019s procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}